Amanda Smith has kicked insulin to the curb in what experts are calling a milestone in the fight against Type 1 diabetes.

A clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with ...

In a small cell therapy trial, 10 out of 12 people with type 1 diabetes no longer needed supplemental insulin, even a year after treatment.

Swiss company PharmaSens and SiBionics have entered a development partnership for niia signature, an all-in-one wearable that integrates the delivery of insulin with continuous glucose monitoring (CGM ...

A GLP-1 in pill form from Eli Lilly shows promising results for weight loss and Type 2 diabetes treatment in a trial. FDA ...

The chief product and customer experience officer said Insulet has seen an uptick in users with Type 2 diabetes since ...

"The medication's going to be 50 percent of your journey, and the other 50 percent is still what you choose to eat and the ...

Sodium-glucose cotransporter-2 (SGLT2) inhibitors are a newer type of medication used to help people with diabetes manage ...

New study results demonstrated the safety and efficacy of the MannKind Afrezza inhaled insulin offering for children with ...

A novel weight loss drug in the same class as semaglutide has successfully met its targets in its largest clinical trial yet, with nearly 90% of participants losing at least 5% of their body weight.

The Biden administration regularly touted its own efforts to lower drug prices, with former president Joe Biden and his allies saying that Medicare’s initiative to negotiate with the ...